Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Ivanna Hrynchak, Emília Sousa, Madalena Pinto & Vera Marisa Costa. (2017) The importance of drug metabolites synthesis: the case-study of cardiotoxic anticancer drugs. Drug Metabolism Reviews 49:2, pages 158-196.
Read now
Read now
Xiaofeng Yang, Yingying Liu, Yanna Zhao, Meihua Han, Yifei Guo, Haixue Kuang & Xiangtao Wang. (2016) A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation. International Journal of Nanomedicine 11, pages 2979-2994.
Read now
Read now
Amit K. Jain & Sanyog Jain. (2016) Advances in oral delivery of anti-cancer prodrugs. Expert Opinion on Drug Delivery 13:12, pages 1759-1775.
Read now
Read now
Wen Lin, Xiangyang Xie, Yanfang Yang, Xudong Fu, Hong Liu, Yang Yang & Jianping Deng. (2016) Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy. Drug Delivery 23:9, pages 3436-3443.
Read now
Read now
Xiangyang Xie, Yanfang Yang, Yang Yang, Hui Zhang, Ying Li & Xingguo Mei. (2016) A photo-responsive peptide- and asparagine–glycine–arginine (NGR) peptide-mediated liposomal delivery system. Drug Delivery 23:7, pages 2445-2456.
Read now
Read now
Ruo Du, Ting Zhong, Wei-Qiang Zhang, Ping Song, Wen-Ding Song, Yang Zhao, Chao Wang, Yi-Qun Tang, Xuan Zhang & Qiang Zhang. (2014) Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid–paclitaxel (CLA-PTX) on B16-F10 melanoma. International Journal of Nanomedicine 9, pages 3091-3105.
Read now
Read now
Awa Dicko, Lawrence D Mayer & Paul G Tardi. (2010) Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo
. Expert Opinion on Drug Delivery 7:12, pages 1329-1341.
Read now
Read now
Gene L Bidwell$suffix/text()$suffix/text() & Drazen Raucher. (2009) Therapeutic peptides for cancer therapy. Part I – peptide inhibitors of signal transduction cascades. Expert Opinion on Drug Delivery 6:10, pages 1033-1047.
Read now
Read now
Michael J Brumlik, Benjamin J Daniel, Reinhard Waehler, David T Curiel, Francis J Giles & Tyler J Curiel. (2008) Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy. Expert Opinion on Drug Delivery 5:1, pages 87-103.
Read now
Read now
Articles from other publishers (67)
Rana Rais, Kathryn M. Lemberg, Lukáš Tenora, Matthew L. Arwood, Arindom Pal, Jesse Alt, Ying Wu, Jenny Lam, Joanna Marie H. Aguilar, Liang Zhao, Diane E. Peters, Carolyn Tallon, Rajeev Pandey, Ajit G. Thomas, Ranjeet P. DashTanguy Seiwert, Pavel Majer, Robert D. Leone, Jonathan D. Powell & Barbara S. Slusher. (2022) Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug. Science Advances 8:46.
Crossref
Crossref
Yue-Yang Liu, Ze-Kun Wang, Shang-Bo Yu, Yamin Liu, Hui Wang, Wei Zhou, Zhan-Ting Li & Dan-Wei Zhang. (2022) Conjugating aldoxorubicin to supramolecular organic frameworks: polymeric prodrugs with enhanced therapeutic efficacy and safety. Journal of Materials Chemistry B 10:22, pages 4163-4171.
Crossref
Crossref
Padakanti Sandeep Chary, Naveen Rajana, Valamla Bhavana, Pankaj Kumar Singh, Saurabh Srivastava, Jitender Madan, Shashi Bala Singh & Neelesh Kumar Mehra. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers
1
24
.
Guanting Li, Bingjun Sun, Shunzhe Zheng, Lu Xu, Wenhui Tao, Dongyang Zhao, Jiang Yu, Shuwen Fu, Xuanbo Zhang, Haotian Zhang, Yinglei Zhai, Cong Luo, Huaiwei Ding, Zhonggui He & Jin Sun. (2021) Zwitterion‐Driven Shape Program of Prodrug Nanoassemblies with High Stability, High Tumor Accumulation, and High Antitumor Activity. Advanced Healthcare Materials 10:23, pages 2101407.
Crossref
Crossref
Maki Kobayashi, Katsuhiko Kojima, Kazutaka Murayama, Yuji Amano, Takashi Koyama, Naoko Ogama, Toshikazu Takeshita, Tatsuro Fukuhara & Nobuyuki Tanaka. (2021) MK‐6, a novel not‐α IL‐2, elicits a potent antitumor activity by improving the effector to regulatory T cell balance. Cancer Science 112:11, pages 4478-4489.
Crossref
Crossref
Suah Yang, Man Kyu Shim, Woo Jun Kim, Jiwoong Choi, Gi-Hoon Nam, Jeongrae Kim, Jinseong Kim, Yujeong Moon, Han Young Kim, Jooho Park, Yoon Park, In-San Kim, Ju Hee Ryu & Kwangmeyung Kim. (2021) Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity. Biomaterials 272, pages 120791.
Crossref
Crossref
Priyanka Maurya, Samipta Singh, Nidhi Mishra, Raviraj Pal, Neelu Singh, Poonam Parashar & Shubhini A. Saraf. 2021. Biopolymer-Based Nanomaterials in Drug Delivery and Biomedical Applications. Biopolymer-Based Nanomaterials in Drug Delivery and Biomedical Applications
465
496
.
Ana V. Vujačić Nikezić, Aleksandra M. Bondžić & Vesna M. Vasić. (2020) Drug delivery systems based on nanoparticles and related nanostructures. European Journal of Pharmaceutical Sciences 151, pages 105412.
Crossref
Crossref
Cristina P. Matos, Yemataw Addis, Patrique Nunes, Sónia Barroso, Irina Alho, Marta Martins, António P.A. Matos, Fernanda Marques, Isabel Cavaco, João Costa Pessoa & Isabel Correia. (2019) Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes. Journal of Inorganic Biochemistry 198, pages 110727.
Crossref
Crossref
Huai-qiu Li, Wei-liang Ye, Meng-lei Huan, Ying Cheng, Dao-zhou Liu, Han Cui, Miao Liu, Bang-le Zhang, Qi-bing Mei & Si-yuan Zhou. (2019) Mitochondria and nucleus delivery of active form of 10-hydroxycamptothecin with dual shell to precisely treat colorectal cancer. Nanomedicine 14:8, pages 1011-1032.
Crossref
Crossref
Jing Gao, Shougang Jiang, Xuewei Zhang, Yujie Fu & Zhiguo Liu. (2019) Preparation, characterization and in vitro activity of a docetaxel–albumin conjugate. Bioorganic Chemistry 83, pages 154-160.
Crossref
Crossref
Monika Mishra, Viney Chawla & Pooja Chawla. (2019) Pectin, beta-cyclodextrin, chitosan and albumin based gastroprotective systems for piroxicam maleate: Synthesis, characterization and biological evaluation. International Journal of Biological Macromolecules 122, pages 127-136.
Crossref
Crossref
Ekaterina A. Litus, Sergei E. Permyakov, Vladimir N. Uversky & Eugene A. Permyakov. (2017) Intrinsically Disordered Regions in Serum Albumin: What Are They For?. Cell Biochemistry and Biophysics 76:1-2, pages 39-57.
Crossref
Crossref
Kumari Varsha, Ankita Sharma, Amanpreet Kaur, Jitender Madan, Ravi S. Pandey, Upendra K. Jain & Ramesh Chandra. 2017. Nanostructures for Cancer Therapy. Nanostructures for Cancer Therapy
775
809
.
Maja Thim Larsen, Matthias Kuhlmann, Michael Lykke Hvam & Kenneth A. Howard. (2016) Albumin-based drug delivery: harnessing nature to cure disease. Molecular and Cellular Therapies 4:1.
Crossref
Crossref
Giulia Suarato, Weiyi Li & Yizhi Meng. (2016)
Role of
p
H-responsiveness in the design of chitosan-based cancer nanotherapeutics: A review
. Biointerphases 11:4.
Crossref
Crossref
Leanna R. Staben, Stefan G. Koenig, Sophie M. Lehar, Richard Vandlen, Donglu Zhang, Josefa Chuh, Shang-Fan Yu, Carl Ng, Jun Guo, Yanzhou Liu, Aimee Fourie-O'Donohue, MaryAnn Go, Xin Linghu, Nathaniel L. Segraves, Tao Wang, Jinhua Chen, BinQing Wei, Gail D. Lewis Phillips, Keyang Xu, Katherine R. Kozak, Sanjeev Mariathasan, John A. Flygare & Thomas H. Pillow. (2016) Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody–drug conjugates. Nature Chemistry 8:12, pages 1112-1119.
Crossref
Crossref
Yanfang Yang, Xiangyang Xie, Xueqing Xu, Xuejun Xia, Hongliang Wang, Lin Li, Wujun Dong, Panpan Ma, Yang Yang, Yuling Liu & Xingguo Mei. (2016) Thermal and magnetic dual-responsive liposomes with a cell-penetrating peptide-siRNA conjugate for enhanced and targeted cancer therapy. Colloids and Surfaces B: Biointerfaces 146, pages 607-615.
Crossref
Crossref
Yang Yang, Xiangyang Xie, Yanfang Yang, Zhiping Li, Fanglin Yu, Wei Gong, Ying Li, Hui Zhang, Zhiyuan Wang & Xingguo Mei. (2016) Polymer Nanoparticles Modified with Photo- and pH-Dual-Responsive Polypeptides for Enhanced and Targeted Cancer Therapy. Molecular Pharmaceutics 13:5, pages 1508-1519.
Crossref
Crossref
Marzena Szwed, Audrey Laroche-Clary, Jacques Robert & Zofia Jozwiak. (2015) Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation. Cellular Oncology 39:2, pages 107-118.
Crossref
Crossref
Jeannette Nilsen, Kine Marita Knudsen Sand, Malin Bern, Peng Lei, Inger Sandlie & Jan Terje Andersen. 2016. Albumin in Medicine. Albumin in Medicine
179
208
.
Wioleta Januchta, Marcin Serocki, Krystyna Dzierzbicka, Grzegorz Cholewi?ski & Andrzej Skladanowski. (2015) Synthesis of functionalized new conjugates of batracylin with tuftsin/retro-tuftsin derivatives and their biological evaluation. European Journal of Medicinal Chemistry 106, pages 85-94.
Crossref
Crossref
Malin Bern, Kine Marita Knudsen Sand, Jeannette Nilsen, Inger Sandlie & Jan Terje Andersen. (2015) The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery. Journal of Controlled Release 211, pages 144-162.
Crossref
Crossref
Yang Yang, YanFang Yang, XiangYang Xie, XingShi Cai, ZhiYuan Wang, Wei Gong, Hui Zhang, Ying Li & XingGuo Mei. (2015) A near-infrared two-photon-sensitive peptide-mediated liposomal delivery system. Colloids and Surfaces B: Biointerfaces 128, pages 427-438.
Crossref
Crossref
Yang Yang, YanFang Yang, XiangYang Xie, ZhiYuan Wang, Wei Gong, Hui Zhang, Ying Li, FangLin Yu, ZhiPing Li & XingGuo Mei. (2015) Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery. Biomaterials 48, pages 84-96.
Crossref
Crossref
Yanfang Yang, Xiangyang Xie, Yang Yang, Hui Zhang & Xingguo Mei. (2015) Photo-Responsive and NGR-Mediated Multifunctional Nanostructured Lipid Carrier for Tumor-Specific Therapy. Journal of Pharmaceutical Sciences 104:4, pages 1328-1339.
Crossref
Crossref
Kine Marita Knudsen Sand, Malin Bern, Jeannette Nilsen, Hanna Theodora Noordzij, Inger Sandlie & Jan Terje Andersen. (2015) Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics. Frontiers in Immunology 5.
Crossref
Crossref
Ruixing Zhang, Xiuli Hu, Fengrui Song, Zhiqiang Liu, Zhigang Xie & Xiabin Jing. (2014) Studies on the biological character of a new pH-sensitive doxorubicin prodrug with tumor targeting using a LC-MS/MS method. Analytical Methods 6:9, pages 3159.
Crossref
Crossref
Cheng Xie, Jun Chang, Xiao-Dong Hao, Jian-Ming Yu, Hong-Rui Liu & Xun Sun. (2013) Mitochondrial-targeted prodrug cancer therapy using a rhodamine B labeled fluorinated docetaxel. European Journal of Pharmaceutics and Biopharmaceutics 85:3, pages 541-549.
Crossref
Crossref
Kaushik Thanki, Rahul P. Gangwal, Abhay T. Sangamwar & Sanyog Jain. (2013) Oral delivery of anticancer drugs: Challenges and opportunities. Journal of Controlled Release 170:1, pages 15-40.
Crossref
Crossref
Ingrid Sassoon & Véronique Blanc. 2013. Antibody-Drug Conjugates. Antibody-Drug Conjugates
1
27
.
Devalingam Mahalingam, Michael J. Brumlik, Reinhard Waehler, David T. Curiel & Tyler J. Curiel. 2013. Cancer Immunotherapy. Cancer Immunotherapy
377
396
.
Amir Azadi, Mehrdad Hamidi, Mohammad-Reza Khoshayand, Mohsen Amini & Mohammad-Reza Rouini. (2012) Preparation and optimization of surface-treated methotrexate-loaded nanogels intended for brain delivery. Carbohydrate Polymers 90:1, pages 462-471.
Crossref
Crossref
Roger Lundblad. 2012. Biotechnology of Plasma Proteins. Biotechnology of Plasma Proteins
83
182
.
Ela Markovsky, Hemda Baabur-Cohen, Anat Eldar-Boock, Liora Omer, Galia Tiram, Shiran Ferber, Paula Ofek, Dina Polyak, Anna Scomparin & Ronit Satchi-Fainaro. (2012) Administration, distribution, metabolism and elimination of polymer therapeutics. Journal of Controlled Release 161:2, pages 446-460.
Crossref
Crossref
Sandrine Dufort, Lucie Sancey & Jean-Luc Coll. (2012) Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution. Advanced Drug Delivery Reviews 64:2, pages 179-189.
Crossref
Crossref
Simone Eichner, Tobias Knobloch, Heinz G. Floss, Jörg Fohrer, Kirsten Harmrolfs, Jekaterina Hermane, Anne Schulz, Florenz Sasse, Peter Spiteller, Florian Taft & Andreas Kirschning. (2011) The Interplay between Mutasynthesis and Semisynthesis: Generation and Evaluation of an Ansamitocin Library. Angewandte Chemie International Edition 51:3, pages 752-757.
Crossref
Crossref
Simone Eichner, Tobias Knobloch, Heinz G. Floss, Jörg Fohrer, Kirsten Harmrolfs, Jekaterina Hermane, Anne Schulz, Florenz Sasse, Peter Spiteller, Florian Taft & Andreas Kirschning. (2011) The Interplay between Mutasynthesis and Semisynthesis: Generation and Evaluation of an Ansamitocin Library. Angewandte Chemie 124:3, pages 776-781.
Crossref
Crossref
Lingling Shan, Sisi Cui, Changli Du, Shunan Wan, Zhiyu Qian, Samuel Achilefu & Yueqing Gu. (2012) A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy. Biomaterials 33:1, pages 146-162.
Crossref
Crossref
Rong-guang Shao & Yong-su Zhen. 2012. Recent Advances in Cancer Research and Therapy. Recent Advances in Cancer Research and Therapy
153
171
.
Barry D. Liboiron, Paul G. Tardi & Lawrence D. Mayer. 2012. Multifunctional Nanoparticles for Drug Delivery Applications. Multifunctional Nanoparticles for Drug Delivery Applications
103
132
.
M. Talelli, K. Morita, C. J. F. Rijcken, R. W. M. Aben, T. Lammers, H. W. Scheeren, C. F. van Nostrum, G. Storm & W. E. Hennink. (2011) Synthesis and Characterization of Biodegradable and Thermosensitive Polymeric Micelles with Covalently Bound Doxorubicin-Glucuronide Prodrug via Click Chemistry. Bioconjugate Chemistry 22:12, pages 2519-2530.
Crossref
Crossref
Jan Terje Andersen & Inger Sandlie. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology
85
120
.
Barry D. Liboiron, Paul G. Tardi, Troy O. Harasym & Lawrence D. Mayer. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology
1013
1050
.
Khalid Abu Ajaj & Felix Kratz. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology
839
884
.
Gurusamy Saravanakumar, Jae Hyung Park, Kwangmeyung Kim & Ick Chan Kwon. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology
701
746
.
David Cragg, Gordon Kingston & David NewmanNicolas Rahier, Craig Thomas & Sidney Hecht. 2011. Anticancer Agents from Natural Products, Second Edition. Anticancer Agents from Natural Products, Second Edition
5
26
.
Fuxing Zhan, Wei Chen, Zhongjuan Wang, Wentao Lu, Ru Cheng, Chao Deng, Fenghua Meng, Haiyan Liu & Zhiyuan Zhong. (2011) Acid-Activatable Prodrug Nanogels for Efficient Intracellular Doxorubicin Release. Biomacromolecules 12:10, pages 3612-3620.
Crossref
Crossref
Patrick R. Connelly, T. Minh Vuong & Mark A. Murcko. (2011) Getting physical to fix pharma. Nature Chemistry 3:9, pages 692-695.
Crossref
Crossref
Xiaoshuang Feng, Julien Pinaud, Elliot L. Chaikof, Daniel Taton & Yves Gnanou. (2011) Sequential functionalization of janus‐type dendrimer‐like poly(ethylene oxide)s with camptothecin and folic acid. Journal of Polymer Science Part A: Polymer Chemistry 49:13, pages 2839-2849.
Crossref
Crossref
Rongzuo Xu, Michael Fisher & R. L. Juliano. (2011) Targeted Albumin-Based Nanoparticles for Delivery of Amphipathic Drugs. Bioconjugate Chemistry 22:5, pages 870-878.
Crossref
Crossref
Yosi Shamay, Lily Adar, Gonen Ashkenasy & Ayelet David. (2011) Light induced drug delivery into cancer cells. Biomaterials 32:5, pages 1377-1386.
Crossref
Crossref
Jan Terje Andersen & Inger Sandlie. 2009. Recombinant Antibodies for Immunotherapy. Recombinant Antibodies for Immunotherapy
293
310
.
Marcelo Calderón, Ralph Graeser, Felix Kratz & Rainer Haag. (2009) Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol. Bioorganic & Medicinal Chemistry Letters 19:14, pages 3725-3728.
Crossref
Crossref
Konstantin H. Dragnev. (2009) In search of the magic bullet. Translational Research 153:6, pages 261-262.
Crossref
Crossref
Khalid Abu Ajaj, Martin L. Biniossek & Felix Kratz. (2009) Development of Protein-Binding Bifunctional Linkers for a New Generation of Dual-Acting Prodrugs. Bioconjugate Chemistry 20:2, pages 390-396.
Crossref
Crossref
Jan Terje Andersen & Inger Sandlie. (2009) The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics. Drug Metabolism and Pharmacokinetics 24:4, pages 318-332.
Crossref
Crossref
S. C. Miller, H. Pan, D. Wang, B. M. Bowman, P. Kopečková & J. Kopeček. (2008) Feasibility of Using a Bone-Targeted, Macromolecular Delivery System Coupled with Prostaglandin E1 to Promote Bone Formation in Aged, Estrogen-Deficient Rats. Pharmaceutical Research 25:12, pages 2889-2895.
Crossref
Crossref
Xin-Ming Liu, Ling-Dong Quan, Jun Tian, Yazen Alnouti, Kai Fu, Geoffrey M. Thiele & Dong Wang. (2008) Synthesis and Evaluation of a Well-defined HPMA Copolymer–Dexamethasone Conjugate for Effective Treatment of Rheumatoid Arthritis. Pharmaceutical Research 25:12, pages 2910-2919.
Crossref
Crossref
Andreas Kirschning, Kirsten Harmrolfs & Tobias Knobloch. (2008) The chemistry and biology of the maytansinoid antitumor agents. Comptes Rendus Chimie 11:11-12, pages 1523-1543.
Crossref
Crossref
Christopher D. Hein, Xin-Ming Liu & Dong Wang. (2008) Click Chemistry, A Powerful Tool for Pharmaceutical Sciences. Pharmaceutical Research 25:10, pages 2216-2230.
Crossref
Crossref
Hiraku Onishi & Yoshiharu Machida. (2008) In Vitro and In Vivo Evaluation of Microparticulate Drug Delivery Systems Composed of Macromolecular Prodrugs. Molecules 13:9, pages 2136-2155.
Crossref
Crossref
Zi Gu, Anita C. Thomas, Zhi Ping Xu, Julie H. Campbell & Gao Qing (Max) Lu. (2008)
In Vitro
Sustained Release of LMWH from MgAl-layered Double Hydroxide Nanohybrids
. Chemistry of Materials 20:11, pages 3715-3722.
Crossref
Crossref
Florian Taft, Marco Brünjes, Heinz G. Floss, Nadine Czempinski, Stephanie Grond, Florenz Sasse & Andreas Kirschning. (2008) Highly Active Ansamitocin Derivatives: Mutasynthesis Using an AHBA-Blocked Mutant. ChemBioChem 9:7, pages 1057-1060.
Crossref
Crossref
Francesca Leonelli, Angela La Bella, Luisa Migneco & Rinaldo Bettolo. (2008) Design, Synthesis and Applications of Hyaluronic Acid-Paclitaxel Bioconjugates†. Molecules 13:2, pages 360-378.
Crossref
Crossref
Felix Kratz, Ivonne A. Müller, Claudia Ryppa & André Warnecke. (2008) Prodrug Strategies in Anticancer Chemotherapy. ChemMedChem 3:1, pages 20-53.
Crossref
Crossref
Kaoru Hida, Justin Hanes & Marc Ostermeier. (2007) Directed evolution for drug and nucleic acid delivery. Advanced Drug Delivery Reviews 59:15, pages 1562-1578.
Crossref
Crossref